about
Ebola Virus Disease: Focus on ChildrenRift valley Fever virus encephalitis is associated with an ineffective systemic immune response and activated T cell infiltration into the CNS in an immunocompetent mouse modelNuclear-cytoplasmic shuttling of C-ABL tyrosine kinaseRift Valley fever virus: Unanswered questions.Rift Valley fever virus vaccine lacking the NSs and NSm genes is safe, nonteratogenic, and confers protection from viremia, pyrexia, and abortion following challenge in adult and pregnant sheep.Ebola hemorrhagic Fever: novel biomarker correlates of clinical outcome.Biomarker correlates of survival in pediatric patients with Ebola virus disease.Andes virus M genome segment is not sufficient to confer the virulence associated with Andes virus in Syrian hamsters.Von Willebrand factor is elevated in individuals infected with Sudan virus and is associated with adverse clinical outcomesHuman Ebola virus infection results in substantial immune activation.The Use of TKM-100802 and Convalescent Plasma in 2 Patients With Ebola Virus Disease in the United StatesRelationship Between Ebola Virus Real-Time Quantitative Polymerase Chain Reaction-Based Threshold Cycle Value and Virus Isolation From Human Plasma.Rift Valley fever virus clearance and protection from neurologic disease are dependent on CD4+ T cell and virus-specific antibody responses.Defining antigen-specific plasmablast and memory B cell subsets in human blood after viral infection or vaccination.Development of a RVFV ELISA that can distinguish infected from vaccinated animals.Cyclin-dependent kinase activity is required at early times for accurate processing and accumulation of the human cytomegalovirus UL122-123 and UL37 immediate-early transcripts and at later times for virus production.Bartonella henselae-mediated disease in solid organ transplant recipients: two pediatric cases and a literature review.Bacillary Angiomatosis in Patients With Cancer: A Pediatric Case Report and a Review of the Literature.A Case of Human Lassa Virus Infection With Robust Acute T-Cell Activation and Long-Term Virus-Specific T-Cell Responses.Kinetic Analysis of Biomarkers in a Cohort of US Patients With Ebola Virus Disease.Ebola Virus Persistence in Semen of Male Survivors.Biomarkers for understanding Ebola virus disease.Clinical care of two patients with Ebola virus disease in the United States.Rift Valley fever virus inhibits a pro-inflammatory response in experimentally infected human monocyte derived macrophages and a pro-inflammatory cytokine response may be associated with patient survival during natural infection.Mechanisms governing maintenance of Cdk1/cyclin B1 kinase activity in cells infected with human cytomegalovirus.Immunogenicity of combination DNA vaccines for Rift Valley fever virus, tick-borne encephalitis virus, Hantaan virus, and Crimean Congo hemorrhagic fever virus.Identification of Dobrava, Hantaan, Seoul, and Puumala viruses by one-step real-time RT-PCR.Development of a reverse genetics system to generate recombinant Marburg virus derived from a bat isolate.Marburgvirus resurgence in Kitaka Mine bat population after extermination attempts, Uganda.Reply to Fedson.Andes virus infection of cynomolgus macaques.The use of recombinant baculoviruses for sustained expression of human cytomegalovirus immediate early proteins in fibroblasts.Rift valley fever viral load correlates with the human inflammatory response and coagulation pathway abnormalities in humans with hemorrhagic manifestations.CD4 T cells, CD8 T cells, and monocytes coordinate to prevent Rift Valley fever virus encephalitisFluorescent Crimean-Congo hemorrhagic fever virus illuminates tissue tropism patterns and identifies early mononuclear phagocytic cell targets in Ifnar-/- mice
P50
Q26824080-B27AC57C-FC0C-460D-B7FC-678A6517D0B1Q28539632-0157CD27-1057-4C80-AFFA-D6FD2DADA483Q28591266-EE188B6C-3203-4BF3-84EA-415F68276FEFQ30151926-BF0F70FE-21B2-4610-B51F-D4CD0B4E7608Q34221766-1C5BCC9E-8278-42AD-9599-167890BCC765Q34229715-CE31B931-423B-4B14-B2D1-D2CAAA5D1D77Q34320456-AC6527B2-155F-4097-A107-4311D120671AQ34334411-381C842C-92E1-4C5F-BA00-6DD19EC72904Q34869398-D8ED362A-B806-4906-925B-E3A989BB4D02Q35485277-D4BCBD73-1690-47D1-B4BC-C9C7B6C83F8BQ35974433-B9D89990-BC5B-4561-8B25-8C60013440E2Q36363682-DAB9767B-843E-4FB0-B5A2-B7322608CCF2Q36827204-F8216C5D-E59E-4922-B2CF-71F43C6F61D4Q37320688-F10F5FC9-B835-4D30-83C1-C439043D3359Q37321966-FAF4CC96-B301-4ACE-927B-6FD8AC08290BQ37567845-AA683E7B-B053-41C0-942B-DBC86A6B904BQ38031997-327FEF68-7BA9-47B3-84F3-EE9DC7132074Q38653347-69DC63EF-A457-49EB-A4FF-3A8315D74064Q40040969-B1A82B62-89D7-48DC-A2AC-622307807670Q40099285-841E2D3E-309E-411B-9170-483159034B94Q40111221-8406A435-2879-430B-A6C7-ED00976B8C83Q40182693-7AD7BD29-5581-4596-B7AE-7A77C0AAE605Q40183261-24209576-593A-49CB-B3E3-BBB3ECED48A6Q40308414-841CE8F3-99F8-4E70-8A14-5CC6A6169FD5Q40344754-F06D08FE-3E22-4B3A-948F-1D7BA139E486Q40498246-C11D675A-0FDD-4D36-BCD7-747951F4DDDCQ40516534-252A8F17-EEC6-42DD-9E8A-B1FFBCB62344Q42266175-1A5672A5-2E1F-45BA-AF9C-830FE76587F9Q42939796-D00CAD7D-EC23-4629-B9D5-65F6B4914B6AQ43221908-A207CACB-AE67-494B-815D-B34F1A2CE9BDQ45730017-60A6AD99-3DD7-497C-A8D1-905CFCBCCB9AQ46037478-C2C188A2-E84F-4354-9A95-28E6D57437DEQ55332018-7A84BEB9-276A-432F-B91E-1C9479494426Q59351865-1C8E17CE-4E39-4FEA-A5BF-38873F7F2D49Q91605105-F31DB174-AEB6-4474-82C8-95B629AAED9C
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Anita McElroy
@en
Anita McElroy
@nl
Anita Mcelroy
@ast
Anita Mcelroy
@es
type
label
Anita McElroy
@en
Anita McElroy
@nl
Anita Mcelroy
@ast
Anita Mcelroy
@es
altLabel
A. K. McElroy
@en
Anita K. McElroy
@en
prefLabel
Anita McElroy
@en
Anita McElroy
@nl
Anita Mcelroy
@ast
Anita Mcelroy
@es
P106
P1153
7005227524
P21
P31
P496
0000-0001-6764-7536